slides · global inventory
Evidence
Beat collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 40,452
Current window 39,121-39,150
Pages 1,349
Rows per page 30
Beat
39,121-39,150 of 40,452
06
The chart uses a dual-axis approach to show price (line) and volume (bars) with annotated callouts for specific events.10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup · 10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup
Deck Investment bank Beat · Market Size1 hit
07
The slide highlights the lack of analyst coverage and low float (34%) resulting in low trading volume for Taro Pharma.10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup · 10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup
Deck Investment bank Beat · Market Size1 hit
09
The slide uses a combination of annual historical/forecast data and half-year comparisons to explain cost structure changes.10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup · 10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup
Deck Investment bank Beat · Financials1 hit
10
Includes a detailed income statement table with Q1, Q2, H1 2012 actuals and 2012 estimates.10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup · 10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup
Deck Investment bank Beat · Financials1 hit
11
10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup · 10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup
Deck Investment bank Beat · Financials1 hit
12
Includes two bar charts showing historical/projected growth and a median benchmark line.10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup · 10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup
Deck Investment bank Beat · FinancialsLoop · Pattern Hunter1 hit
13
Taro is highlighted in blue in each chart, while peers are in grey. Medians are indicated by red dashed lines.10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup · 10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup
Deck Investment bank Beat · FinancialsLoop · Pattern Hunter1 hit
14
Includes specific footnotes regarding adjustments for peer data (e.g., Actavis, Paddock, Flomax).10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup · 10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup
Deck Investment bank Beat · FinancialsLoop · Pattern Hunter1 hit
22
This appears to be a page from a book or a long-form essay rather than a traditional slide deck.11 laws of showrunning nice version · 11-laws-of-showrunning-nice-version
Deck Investor relations Beat · Visualization1 hit
23
This appears to be a page from a book or long-form document rather than a traditional slide deck.11 laws of showrunning nice version · 11-laws-of-showrunning-nice-version
Deck Investor relations Beat · Visualization1 hit
09
Uses a football field chart visualization to compare valuation ranges against specific transaction prices.1 IBD presentation 2021 Fbl Financial Group Inc Barclays Capital · 1-ibd-presentation-2021-fbl-financial-group-inc-barclays-capital
Deck Investment bank Beat · Evidence & ProofLoop · Pattern Hunter1 hit
10
Includes specific footnotes regarding data sources and definitions for unaffected price and pre-COVID periods.1 IBD presentation 2021 Fbl Financial Group Inc Barclays Capital · 1-ibd-presentation-2021-fbl-financial-group-inc-barclays-capital
Deck Investment bank Beat · Evidence & ProofLoop · Pattern Hunter1 hit
11
1 IBD presentation 2021 Fbl Financial Group Inc Barclays Capital1 IBD presentation 2021 Fbl Financial Group Inc Barclays Capital · 1-ibd-presentation-2021-fbl-financial-group-inc-barclays-capital
Deck Investment bank Beat · Evidence & ProofLoop · Pattern Hunter1 hit
12
1 IBD presentation 2021 Fbl Financial Group Inc Barclays Capital1 IBD presentation 2021 Fbl Financial Group Inc Barclays Capital · 1-ibd-presentation-2021-fbl-financial-group-inc-barclays-capital
Deck Investment bank Beat · Evidence & ProofLoop · Pattern Hunter1 hit
13
Includes peer comparison charts for Protection and Annuity segments, a segment contribution breakdown, and a detailed valuation table.1 IBD presentation 2021 Fbl Financial Group Inc Barclays Capital · 1-ibd-presentation-2021-fbl-financial-group-inc-barclays-capital
Deck Investment bank Beat · Evidence & ProofLoop · Pattern Hunter1 hit
14
Includes a regression analysis with R-squared values and an implied valuation range for FFG.1 IBD presentation 2021 Fbl Financial Group Inc Barclays Capital · 1-ibd-presentation-2021-fbl-financial-group-inc-barclays-capital
Deck Investment bank Beat · Evidence & Proof1 hit
15
1 IBD presentation 2021 Fbl Financial Group Inc Barclays Capital1 IBD presentation 2021 Fbl Financial Group Inc Barclays Capital · 1-ibd-presentation-2021-fbl-financial-group-inc-barclays-capital
Deck Investment bank Beat · Evidence & Proof1 hit
16
The slide uses a comparison matrix structure to contrast the American Equity/Athene/MassMutual deal with the Global Atlantic/KKR deal.1 IBD presentation 2021 Fbl Financial Group Inc Barclays Capital · 1-ibd-presentation-2021-fbl-financial-group-inc-barclays-capital
Deck Investment bank Beat · Evidence & Proof1 hit
17
1 IBD presentation 2021 Fbl Financial Group Inc Barclays Capital1 IBD presentation 2021 Fbl Financial Group Inc Barclays Capital · 1-ibd-presentation-2021-fbl-financial-group-inc-barclays-capital
Deck Investment bank Beat · Evidence & Proof1 hit
18
Includes detailed footnotes regarding methodology and data sources for the valuation.1 IBD presentation 2021 Fbl Financial Group Inc Barclays Capital · 1-ibd-presentation-2021-fbl-financial-group-inc-barclays-capital
Deck Investment bank Beat · Evidence & Proof1 hit
19
Three separate sensitivity tables (Cost of Equity vs Growth Rate, Expense Savings, and RBC Ratio).1 IBD presentation 2021 Fbl Financial Group Inc Barclays Capital · 1-ibd-presentation-2021-fbl-financial-group-inc-barclays-capital
Deck Investment bank Beat · Evidence & Proof1 hit
20
1 IBD presentation 2021 Fbl Financial Group Inc Barclays Capital1 IBD presentation 2021 Fbl Financial Group Inc Barclays Capital · 1-ibd-presentation-2021-fbl-financial-group-inc-barclays-capital
Deck Investment bank Beat · Evidence & Proof1 hit
21
1 IBD presentation 2021 Fbl Financial Group Inc Barclays Capital1 IBD presentation 2021 Fbl Financial Group Inc Barclays Capital · 1-ibd-presentation-2021-fbl-financial-group-inc-barclays-capital
Deck Investment bank Beat · Evidence & Proof1 hit
22
Includes statutory book value, existing business value, and 10-year new business projections.1 IBD presentation 2021 Fbl Financial Group Inc Barclays Capital · 1-ibd-presentation-2021-fbl-financial-group-inc-barclays-capital
Deck Investment bank Beat · Evidence & Proof1 hit
23
The slide uses a waterfall-style bridge calculation to adjust actuarial value for various business segments and holding company assets/liabilities.1 IBD presentation 2021 Fbl Financial Group Inc Barclays Capital · 1-ibd-presentation-2021-fbl-financial-group-inc-barclays-capital
Deck Investment bank Beat · Evidence & Proof1 hit
14
GitLab | Investor Presentation Deck | 47 slidesGitLab | Investor Presentation Deck | 47 slides · GitLab
Pitch deck Investor relations Beat · Competition1 hit
22
GitLab | Investor Presentation Deck | 47 slidesGitLab | Investor Presentation Deck | 47 slides · GitLab
Pitch deck Investor relations Beat · Business Model1 hit
23
GitLab | Investor Presentation Deck | 47 slidesGitLab | Investor Presentation Deck | 47 slides · GitLab
Pitch deck Investor relations Beat · Business Model1 hit
24
GitLab | Investor Presentation Deck | 47 slidesGitLab | Investor Presentation Deck | 47 slides · GitLab
Pitch deck Investor relations Beat · Business Model1 hit
25
GitLab | Investor Presentation Deck | 47 slidesGitLab | Investor Presentation Deck | 47 slides · GitLab
Pitch deck Investor relations Beat · Business Model1 hit